LBTD (Lotus Bio-Technology Development) Total Stockholders Equity: $-0.06 Mil (As of Dec. 2017)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Lotus Bio-Technology Development Total Stockholders Equity?

Lotus Bio-Technology Development LBTD -99.99% Total Stockholders Equity is $-0.06 Mil as of Dec. 2017.

Lotus Bio-Technology Development's Total Stockholders Equity for the quarter that ended in Dec. 2017 was $-0.06 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Lotus Bio-Technology Development's Book Value per Share for the quarter that ended in Dec. 2017 was $-0.00. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Lotus Bio-Technology Development's Debt-to-Equity for the quarter that ended in Dec. 2017 was 0.00.

Lotus Bio-Technology Development  (OTCPK:LBTD) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Lotus Bio-Technology Development's Book Value per Share for the quarter that ended in Dec. 2017 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(-0.061-0)/782.776
=-0.00

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Lotus Bio-Technology Development's Debt-to-Equity for the quarter that ended in Dec. 2017 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0 + 0) / -0.061
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lotus Bio-Technology Development Total Stockholders Equity Related Terms

Lotus Bio-Technology Development Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Lotus Bio-Technology Development's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lotus Bio-Technology Development Total Stockholders Equity Chart

Lotus Bio-Technology Development Annual Data
Trend Mar11 Mar12 Mar13 Mar14 Mar15 Mar16 Mar17
Total Stockholders Equity
Get a 7-Day Free Trial -0.01 -0.03 -0.05 -0.06 -0.08

Lotus Bio-Technology Development Quarterly Data
Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.08 -0.08 0.00 0.00 -0.06
What does a Total Stockholders Equity of $-0.06 Mil mean?
Lotus Bio-Technology Development (LBTD) has a Total Stockholders Equity of $-0.06 Mil as of Dec. 2017. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Lotus Bio-Technology Development and its competitors.
Is Lotus Bio-Technology Development's Total Stockholders Equity too high?
Lotus Bio-Technology Development's current Total Stockholders Equity is $-0.06 Mil.
How does Lotus Bio-Technology Development's Total Stockholders Equity compare to SNES and CVAT?
Lotus Bio-Technology Development's Total Stockholders Equity of $-0.06 Mil can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for an Agriculture company?
A good Total Stockholders Equity depends on the Agriculture industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Lotus Bio-Technology Development and its competitors. Lotus Bio-Technology Development's current Total Stockholders Equity is $-0.06 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lotus Bio-Technology Development stock overvalued right now?
Lotus Bio-Technology Development (LBTD) has a current Total Stockholders Equity of $-0.06 Mil. The current Total Stockholders Equity is $-0.06 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Lotus Bio-Technology Development (LBTD), the current Total Stockholders Equity is $-0.06 Mil as of Dec. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lotus Bio-Technology Development Business Description

Address 108 2559 Parkview Lane, Port Coquitlam, BC, CAN, V3C6M1
Lotus Bio-Technology Development Corp is actively seeking out new opportunities in the Organic and Bio-technology space.